In models of hypercholesterolemia, probucol was found to upregulate hepatic SR-BI expression, leading to accelerated direct HDL-C ester clearance along with stimulation of the LDLR-dependent pathways (Takiguchi et al., 2018). The gene discussed is LDLR; the disease is familial hypercholesterolemia.